by Igen BioLab Group | Oct 9, 2020 | News, Press releases, Publications
Javier Asarta, CEO of the Igen Biolab Group: “AMD affects some 700,000 people in Spain and currently has no treatment”.Dr Jordi Monés, study author: “As well as the medical benefits for patients, it reduces the socio-economic burden by preventing or improving the...
by Igen BioLab Group | Apr 23, 2020 | News
Many genomic studies have revealed associations between the gut microbiota composition and host meta- bolism. These observations led to the idea that a causal relationship could exist between the microbiota and metabolic diseases, a concept supported by studies...
by Igen BioLab Group | Mar 2, 2020 | News
Cancer mutations can be caused by common gut bacteria carried by many people. This was demonstrated by researchers from the Hubrecht Institute (KNAW) and Princess Máxima Center in Utrecht, the Netherlands. By exposing cultured human mini-guts to a particular strain of...
by Igen BioLab Group | Feb 25, 2020 | News
Checkpoint inhibitors have revolutionized cancer therapy but only work in a subset of patients and can lead to a multitude of toxicities, suggesting the need for more targeted delivery systems. Because of their preferential colonization of tumors, microbes are a...
by Igen BioLab Group | Feb 18, 2020 | News
Micro-organisms in the gut support healthy digestion by helping nerve cells within the intestine to regulate the contraction and relaxation of the muscle wall of the colon, according to new research from the Crick and Bern University. The study, published in Nature,...
